12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Monday's pre-market session, with 6 gainers and 6 losers. Notable gainers include Chinook Therapeutics (KDNY) and Streamline Health Solutions (STRM), while Oncorus (ONCR) and Oncology Institute (TOI) were among the losers.

June 12, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Chinook Therapeutics (KDNY) stock rose by 57.1% to $37.69 during Monday's pre-market session, with a market value of $2.5 billion.
Chinook Therapeutics' stock price rose significantly during the pre-market session, indicating a positive short-term impact. The 57.1% increase in stock price suggests strong investor interest and potential for further gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Streamline Health Solutions (STRM) shares increased by 12.92% to $1.66 during Monday's pre-market session, with a market value of $97.2 million. The company's Q1 earnings were released today.
Streamline Health Solutions' stock price increased by 12.92% during the pre-market session, indicating a positive short-term impact. The release of the company's Q1 earnings today may have contributed to the stock's upward movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Oncorus (ONCR) shares fell by 29.1% to $0.07 during Monday's pre-market session, with a market value of $1.8 million.
Oncorus' stock price decreased significantly during the pre-market session, indicating a negative short-term impact. The 29.1% decline in stock price suggests a lack of investor confidence and potential for further losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Oncology Institute (TOI) stock fell by 14.68% to $0.53 during Monday's pre-market session, with a market value of $39.8 million.
Oncology Institute's stock price decreased by 14.68% during the pre-market session, indicating a negative short-term impact. The decline in stock price suggests a lack of investor confidence and potential for further losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100